COVID-19 Trial Vaccinations

Home vaccinations

The Programme recognises the importance of representing the Aotearoa New Zealand population in international clinical trials and values their contribution to new COVID-19 vaccine research. The COVID-19 Trial Vaccinations and Vaccination Certificates Policy Statement provides a policy statement on the decisions and implications for consumers considering or participating in Medsafe approved COVID-19 clinical trial in Aotearoa New Zealand.

COVID-19 Trial Vaccinations

Next Article

Home vaccinations

More articles from this publication:

Home vaccinations

Mobile vaccination team

Appendix K: Vaccination practice variation according to the COVID-19 Protection Framework changes

Appendix J: Risk mitigations for vaccination sites

Appendix G: Vaccination site screening questions

Variations

Appendix D: Logistics and inventory management

National Immunisation Booking System

Incidents

This article is from:

NIP-operating-guidelines-v47